Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension
- 9 January 2024
- Vol. 165 (6) , 1518-1533
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute
- NIH (R01HL152832)
This publication has 82 references indexed in Scilit:
- Lung Transplantation for Pulmonary Arterial HypertensionChest, 2023
- Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure2019
- Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trialDrug and Alcohol Dependence, 2018
- 17β-estradiol suppresses carboxylesterases by activating c-Jun/AP-1 pathway in primary human and mouse hepatocytesEuropean Journal of Pharmacology, 2018
- Inhibition of protein tyrosine phosphatases unmasks vasoconstriction and potentiates calcium signaling in rat aorta smooth muscle cells in response to an agonist of 5-HT2B receptors BW723C86Biochemical and Biophysical Research Communications, 2017
- Methamphetamine induces the release of endothelinJournal of Neuroscience Research, 2015
- Reactive Oxygen Species in Pulmonary Vascular Remodeling2013
- Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findingsDrug and Alcohol Dependence, 2013
- Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposureMetabolomics, 2012
- Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular BasisThe American Journal of Human Genetics, 2008